Copyright Reports & Markets. All rights reserved.

Global Enalapril Market Research Report 2021

Buy now

1 Enalapril Market Overview

  • 1.1 Product Overview and Scope of Enalapril
  • 1.2 Enalapril Segment by Type
    • 1.2.1 Global Enalapril Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 2.5mg
    • 1.2.3 5mg
    • 1.2.4 10mg
    • 1.2.5 20mg
  • 1.3 Enalapril Segment by Application
    • 1.3.1 Enalapril Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Drugs Store
  • 1.4 Global Enalapril Market Size Estimates and Forecasts
    • 1.4.1 Global Enalapril Revenue 2016-2027
    • 1.4.2 Global Enalapril Sales 2016-2027
    • 1.4.3 Enalapril Market Size by Region: 2016 Versus 2021 Versus 2027

2 Enalapril Market Competition by Manufacturers

  • 2.1 Global Enalapril Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Enalapril Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Enalapril Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Enalapril Manufacturing Sites, Area Served, Product Type
  • 2.5 Enalapril Market Competitive Situation and Trends
    • 2.5.1 Enalapril Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Enalapril Players Market Share by Revenue
    • 2.5.3 Global Enalapril Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Enalapril Retrospective Market Scenario by Region

  • 3.1 Global Enalapril Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Enalapril Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Enalapril Market Facts & Figures by Country
    • 3.3.1 North America Enalapril Sales by Country
    • 3.3.2 North America Enalapril Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Enalapril Market Facts & Figures by Country
    • 3.4.1 Europe Enalapril Sales by Country
    • 3.4.2 Europe Enalapril Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Enalapril Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Enalapril Sales by Region
    • 3.5.2 Asia Pacific Enalapril Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Enalapril Market Facts & Figures by Country
    • 3.6.1 Latin America Enalapril Sales by Country
    • 3.6.2 Latin America Enalapril Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Enalapril Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Enalapril Sales by Country
    • 3.7.2 Middle East and Africa Enalapril Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Enalapril Historic Market Analysis by Type

  • 4.1 Global Enalapril Sales Market Share by Type (2016-2021)
  • 4.2 Global Enalapril Revenue Market Share by Type (2016-2021)
  • 4.3 Global Enalapril Price by Type (2016-2021)

5 Global Enalapril Historic Market Analysis by Application

  • 5.1 Global Enalapril Sales Market Share by Application (2016-2021)
  • 5.2 Global Enalapril Revenue Market Share by Application (2016-2021)
  • 5.3 Global Enalapril Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Apotex Inc
    • 6.1.1 Apotex Inc Corporation Information
    • 6.1.2 Apotex Inc Description and Business Overview
    • 6.1.3 Apotex Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Apotex Inc Product Portfolio
    • 6.1.5 Apotex Inc Recent Developments/Updates
  • 6.2 Apothecon Inc Div Bristol Myers Squibb
    • 6.2.1 Apothecon Inc Div Bristol Myers Squibb Corporation Information
    • 6.2.2 Apothecon Inc Div Bristol Myers Squibb Description and Business Overview
    • 6.2.3 Apothecon Inc Div Bristol Myers Squibb Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Apothecon Inc Div Bristol Myers Squibb Product Portfolio
    • 6.2.5 Apothecon Inc Div Bristol Myers Squibb Recent Developments/Updates
  • 6.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
    • 6.3.1 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Corporation Information
    • 6.3.2 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Description and Business Overview
    • 6.3.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Product Portfolio
    • 6.3.5 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Developments/Updates
  • 6.4 Krka Dd Novo Mesto
    • 6.4.1 Krka Dd Novo Mesto Corporation Information
    • 6.4.2 Krka Dd Novo Mesto Description and Business Overview
    • 6.4.3 Krka Dd Novo Mesto Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Krka Dd Novo Mesto Product Portfolio
    • 6.4.5 Krka Dd Novo Mesto Recent Developments/Updates
  • 6.5 Lek Pharmaceuticals D D
    • 6.5.1 Lek Pharmaceuticals D D Corporation Information
    • 6.5.2 Lek Pharmaceuticals D D Description and Business Overview
    • 6.5.3 Lek Pharmaceuticals D D Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Lek Pharmaceuticals D D Product Portfolio
    • 6.5.5 Lek Pharmaceuticals D D Recent Developments/Updates
  • 6.6 Mylan Pharmaceuticals Inc
    • 6.6.1 Mylan Pharmaceuticals Inc Corporation Information
    • 6.6.2 Mylan Pharmaceuticals Inc Description and Business Overview
    • 6.6.3 Mylan Pharmaceuticals Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Mylan Pharmaceuticals Inc Product Portfolio
    • 6.6.5 Mylan Pharmaceuticals Inc Recent Developments/Updates
  • 6.7 Ranbaxy Laboratories Ltd
    • 6.6.1 Ranbaxy Laboratories Ltd Corporation Information
    • 6.6.2 Ranbaxy Laboratories Ltd Description and Business Overview
    • 6.6.3 Ranbaxy Laboratories Ltd Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Ranbaxy Laboratories Ltd Product Portfolio
    • 6.7.5 Ranbaxy Laboratories Ltd Recent Developments/Updates
  • 6.8 Sandoz Inc
    • 6.8.1 Sandoz Inc Corporation Information
    • 6.8.2 Sandoz Inc Description and Business Overview
    • 6.8.3 Sandoz Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Sandoz Inc Product Portfolio
    • 6.8.5 Sandoz Inc Recent Developments/Updates
  • 6.9 Taro Pharmaceutical Industries Ltd
    • 6.9.1 Taro Pharmaceutical Industries Ltd Corporation Information
    • 6.9.2 Taro Pharmaceutical Industries Ltd Description and Business Overview
    • 6.9.3 Taro Pharmaceutical Industries Ltd Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Taro Pharmaceutical Industries Ltd Product Portfolio
    • 6.9.5 Taro Pharmaceutical Industries Ltd Recent Developments/Updates
  • 6.10 Teva Pharmaceuticals Usa Inc
    • 6.10.1 Teva Pharmaceuticals Usa Inc Corporation Information
    • 6.10.2 Teva Pharmaceuticals Usa Inc Description and Business Overview
    • 6.10.3 Teva Pharmaceuticals Usa Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Teva Pharmaceuticals Usa Inc Product Portfolio
    • 6.10.5 Teva Pharmaceuticals Usa Inc Recent Developments/Updates
  • 6.11 Watson Laboratories Inc
    • 6.11.1 Watson Laboratories Inc Corporation Information
    • 6.11.2 Watson Laboratories Inc Enalapril Description and Business Overview
    • 6.11.3 Watson Laboratories Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Watson Laboratories Inc Product Portfolio
    • 6.11.5 Watson Laboratories Inc Recent Developments/Updates
  • 6.12 Wockhardt Americas Inc
    • 6.12.1 Wockhardt Americas Inc Corporation Information
    • 6.12.2 Wockhardt Americas Inc Enalapril Description and Business Overview
    • 6.12.3 Wockhardt Americas Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Wockhardt Americas Inc Product Portfolio
    • 6.12.5 Wockhardt Americas Inc Recent Developments/Updates
  • 6.13 Biovail Laboratories International Srl
    • 6.13.1 Biovail Laboratories International Srl Corporation Information
    • 6.13.2 Biovail Laboratories International Srl Enalapril Description and Business Overview
    • 6.13.3 Biovail Laboratories International Srl Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Biovail Laboratories International Srl Product Portfolio
    • 6.13.5 Biovail Laboratories International Srl Recent Developments/Updates
  • 6.14 Bedford Laboratories Div Ben Venue Laboratories Inc
    • 6.14.1 Bedford Laboratories Div Ben Venue Laboratories Inc Corporation Information
    • 6.14.2 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Description and Business Overview
    • 6.14.3 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Bedford Laboratories Div Ben Venue Laboratories Inc Product Portfolio
    • 6.14.5 Bedford Laboratories Div Ben Venue Laboratories Inc Recent Developments/Updates
  • 6.15 Hikma Farmaceutica (Portugal) Sa
    • 6.15.1 Hikma Farmaceutica (Portugal) Sa Corporation Information
    • 6.15.2 Hikma Farmaceutica (Portugal) Sa Enalapril Description and Business Overview
    • 6.15.3 Hikma Farmaceutica (Portugal) Sa Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Hikma Farmaceutica (Portugal) Sa Product Portfolio
    • 6.15.5 Hikma Farmaceutica (Portugal) Sa Recent Developments/Updates
  • 6.16 Hospira Inc
    • 6.16.1 Hospira Inc Corporation Information
    • 6.16.2 Hospira Inc Enalapril Description and Business Overview
    • 6.16.3 Hospira Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Hospira Inc Product Portfolio
    • 6.16.5 Hospira Inc Recent Developments/Updates
  • 6.17 Teva Parenteral Medicines Inc
    • 6.17.1 Teva Parenteral Medicines Inc Corporation Information
    • 6.17.2 Teva Parenteral Medicines Inc Enalapril Description and Business Overview
    • 6.17.3 Teva Parenteral Medicines Inc Enalapril Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Teva Parenteral Medicines Inc Product Portfolio
    • 6.17.5 Teva Parenteral Medicines Inc Recent Developments/Updates

7 Enalapril Manufacturing Cost Analysis

  • 7.1 Enalapril Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Enalapril
  • 7.4 Enalapril Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Enalapril Distributors List
  • 8.3 Enalapril Customers

9 Enalapril Market Dynamics

  • 9.1 Enalapril Industry Trends
  • 9.2 Enalapril Growth Drivers
  • 9.3 Enalapril Market Challenges
  • 9.4 Enalapril Market Restraints

10 Global Market Forecast

  • 10.1 Enalapril Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Enalapril by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Enalapril by Type (2022-2027)
  • 10.2 Enalapril Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Enalapril by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Enalapril by Application (2022-2027)
  • 10.3 Enalapril Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Enalapril by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Enalapril by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    2.5mg
    5mg
    10mg
    20mg

    Segment by Application
    Hospital
    Drugs Store

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Apotex Inc
    Apothecon Inc Div Bristol Myers Squibb
    Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
    Krka Dd Novo Mesto
    Lek Pharmaceuticals D D
    Mylan Pharmaceuticals Inc
    Ranbaxy Laboratories Ltd
    Sandoz Inc
    Taro Pharmaceutical Industries Ltd
    Teva Pharmaceuticals Usa Inc
    Watson Laboratories Inc
    Wockhardt Americas Inc
    Biovail Laboratories International Srl
    Bedford Laboratories Div Ben Venue Laboratories Inc
    Hikma Farmaceutica (Portugal) Sa
    Hospira Inc
    Teva Parenteral Medicines Inc

    Buy now